Rubius Therapeutics, Inc. (RUBY:NASDAQ) jumped higher at $0.93, representing a gain of 23.4%. On Fri, Sep 02, 2022, RUBY:NASDAQ touched a New 2-Week High of $0.93. The stock appeared on our News Catalysts scanner on Tue, Aug 09, 2022 at 10:38 AM in the 'INVESTOR UPDATE' category. From Fri, Aug 19, 2022, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Jun 08, 2022 at $1.57 with a volume of 4M+.
About Rubius Therapeutics, Inc. (RUBY:NASDAQ)
Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.
Top 10 Gainers:
- Venus Concept Inc. (VERO:NASDAQ), 54.87%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- PaxMedica Inc. (PXMD:NASDAQ), 47.71%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 35.29%
- Sunrise New Energy Co. Ltd Ord (EPOW:NASDAQ), 31.46%
- Advanced Human Imaging Limited. (AHI:NASDAQ), 29.1%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 23.39%
- Pear Therapeutics Inc. (PEAR:NASDAQ), 21.71%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 21.38%
- New Age Beverages Corporation (NBEV:NASDAQ), 21.28%